<DOC>
	<DOCNO>NCT01371396</DOCNO>
	<brief_summary>The purpose study understand Hispanics overweight high incidence fatty liver disease .</brief_summary>
	<brief_title>Effect Dietary Macronutrient Composition</brief_title>
	<detailed_description>Obesity major factor drive increase prevalence hepatic steatosis US . However , little known regard relationship dietary intake hepatic fat deposition factor promote loss hepatic steatosis . Here , investigator determine difference dietary composition affect development regression fatty liver . The investigator hypothesize Hispanic subject metabolic syndrome high liver fat synthesis rate compare African American subject . Using detailed vivo , serial measurement fuel metabolism ( GC/MS NMR ) fatty acid metabolism measure liver periphery . This first study two methodology use together assess glucose fatty acid metabolism subject . Subjects test dietary weight-loss intervention produce 6 % body weight loss 5 month . The specific aim follow : AIM 1 : Determine contribution peripheral dietary fat liver-TG Hispanics African Americans metabolic syndrome . Hypothesis : De novo lipogenesis contribute liver-TG great quantity compare African Americans . AIM 2 : Determine effect low-CHO low-fat diet liver fat regression . Hypothesis : Compared low-fat diet , low-CHO diet markedly decrease marker inflammation coincident great improvement insulin sensitivity assess intravenous glucose tolerance test .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Elevated serum ALT metabolic syndrome African American Hispanic Nondiabetic Men woman Smokers nonsmoker Pre postmenopausal ( +/ HRT ) Stable body weight Age 2065 year BMI 2545 kg/m2 Diabetes Pregnancy Ethanol intake : male &gt; 140 g/week , females &gt; 70 g/week Chronic hepatitis B chronic hepatitis C Hemochromatosis Wilson 's Disease Autoimmune hepatitis primary biliary cirrhosis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Metabolic syndrome</keyword>
	<keyword>Non-alcoholic fatty liver disease</keyword>
	<keyword>Obesity Metabolism</keyword>
	<keyword>Stable isotope</keyword>
	<keyword>Dietary weight loss</keyword>
</DOC>